evidence table
Black Seed Oil Blood Pressure Meta-Analysis Evidence Table
Structured evidence table for Black Seed Oil Blood Pressure Meta-Analysis, generated from 2 reusable source documents in the Migaku knowledge base.
| topic | claim | evidence level | citation | source |
|---|---|---|---|---|
| Black Seed Oil Blood Pressure Meta-Analysis | These conditions do not operate in isolation; they directly promote atherosclerosis and cardiovascular damage by exacerbating a cluster of intermediate, modifiable cardiovascular risk factors. | 1 | Musazadeh Vali (2026) | The Effect of Nigella sativa Supplementation on Cardiometabolic Health in Patients With Metabolic Diseases: A GRADE ‐Assessed Systematic Review and Meta‐Analysis |
| Black Seed Oil Blood Pressure Meta-Analysis | This cluster includes hypertension, dysglycemia (elevated fasting glucose and HbA1c), insulin resistance, and adverse body composition (e.g., increased central adiposity) [,]. | 1 | Musazadeh Vali (2026) | The Effect of Nigella sativa Supplementation on Cardiometabolic Health in Patients With Metabolic Diseases: A GRADE ‐Assessed Systematic Review and Meta‐Analysis |
| Black Seed Oil Blood Pressure Meta-Analysis | Consequently, the management of metabolic diseases is fundamentally linked to the management of cardiovascular risk, with therapeutic strategies often targeting these same intermediate factors to reduce long‐term CVD events [,]. | 1 | Musazadeh Vali (2026) | The Effect of Nigella sativa Supplementation on Cardiometabolic Health in Patients With Metabolic Diseases: A GRADE ‐Assessed Systematic Review and Meta‐Analysis |
| Black Seed Oil Blood Pressure Meta-Analysis | 1 2 3 4 5 6 7 8 9 10 Cardiovascular diseases (CVDs) remain the leading cause of global morbidity and mortality. | 1 | Musazadeh Vali (2026) | The Effect of Nigella sativa Supplementation on Cardiometabolic Health in Patients With Metabolic Diseases: A GRADE ‐Assessed Systematic Review and Meta‐Analysis |
| Black Seed Oil Blood Pressure Meta-Analysis | ) supplementation may offer beneficial effects in modulating various cardiometabolic risk factors, although findings from clinical trials have been inconsistent. | 4 | Kuo WH (2026) | Integrative Evidence on Sesame Supplementation for Cardiometabolic Risk Factors Relevant to Retinopathy. |
| Black Seed Oil Blood Pressure Meta-Analysis | Sesame supplementation significantly reduced both systolic and diastolic blood pressure. | 4 | Kuo WH (2026) | Integrative Evidence on Sesame Supplementation for Cardiometabolic Risk Factors Relevant to Retinopathy. |
| Black Seed Oil Blood Pressure Meta-Analysis | Further-more, sesame intake was associated with a significant reduction in liver enzyme levels, particularly alanine aminotransferase (ALT). | 4 | Kuo WH (2026) | Integrative Evidence on Sesame Supplementation for Cardiometabolic Risk Factors Relevant to Retinopathy. |
| Black Seed Oil Blood Pressure Meta-Analysis | Background Cardiometabolic disorders, such as diabetes, hypertension, dyslipidemia, retinopathy, and non-alcoholic fatty liver disease, present significant health challenges globally. | 4 | Kuo WH (2026) | Integrative Evidence on Sesame Supplementation for Cardiometabolic Risk Factors Relevant to Retinopathy. |
Source documents